Literature DB >> 14289998

CRITICAL EVALUATION OF MAMMOGRAPHY IN THE MANAGEMENT OF BREAST DISEASE.

A OCHSNER, W E GRIFFITH.   

Abstract

Keywords:  BREAST; BREAST DISEASES; BREAST NEOPLASMS; MAMMOGRAPHY; NEOPLASM DIAGNOSIS; RADIOGRAPHY

Mesh:

Year:  1965        PMID: 14289998      PMCID: PMC1409066          DOI: 10.1097/00000658-196505000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  8 in total

1.  MAMMOGRAPHY: REPORT ON ITS USE IN WOMEN WITH BREASTS ABNORMAL AND NORMAL ON PHYSICAL EXAMINATION.

Authors:  J N WOLFE
Journal:  Radiology       Date:  1964-08       Impact factor: 11.105

2.  EXPERIENCES WITH MAMMOGRAPHY IN A TEACHING HOSPITAL.

Authors:  W J BEAN; C M NICE
Journal:  South Med J       Date:  1964-10       Impact factor: 0.954

3.  MAMMOGRAPHY: ADVANTAGES AND LIMITATIONS.

Authors:  D M WITTEN
Journal:  Postgrad Med       Date:  1964-09       Impact factor: 3.840

4.  MAMMOGRAPHY OF CANCER.

Authors:  J GERSHON-COHEN; M FORMAN
Journal:  Bull N Y Acad Med       Date:  1964-09

5.  Roentgenography of the breast.

Authors:  V KREMENS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1958-12

6.  Experience with mammography in a tumor institution. Evaluation of 1,000 studies.

Authors:  R L EGAN
Journal:  Radiology       Date:  1960-12       Impact factor: 11.105

7.  An improved method in diagnostic roentgenography of the breast.

Authors:  M M LINDELL; J J BOYLE
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1961-07

8.  An analysis of 1500 breast biopsies.

Authors:  F M MASSIE; J T MCCLELLAN
Journal:  Am Surg       Date:  1960-08       Impact factor: 0.688

  8 in total
  1 in total

1.  The diagnostic accuracy of palpation and fine-needle biopsy and an evaluation of their combined use in the diagnosis of breast lesions: report on a prospective study in 1244 women with symptoms.

Authors:  A Rimsten; B Stenkvist; H Johanson; A Lindgren
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.